WATSON PHARMACEUTICALS, INC., as Issuer and Wells Fargo Bank, National Association, as Trustee THIRD SUPPLEMENTAL INDENTURE Dated as of October 2, 2012 to the Indenture dated as of August 24, 2009 1.875% Senior Notes due 2017 3.250% Senior Notes due...Third Supplemental Indenture • October 2nd, 2012 • Watson Pharmaceuticals Inc • Pharmaceutical preparations • New York
SUPPLEMENTAL INDENTURE (this “Third Supplemental Indenture”), dated as of October 2, 2012, between WATSON PHARMACEUTICALS, INC., a Nevada corporation (the “Company”), and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee (the “Trustee”).
